NM HEALTH: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
NM HEALTH
Largest movements
- Cash -€789
down €789 (-43.4%), from €1,816 to €1,027
mainly Net result for the year (-€1,207) and Trade debts (-€128)
- Tangible fixed assets -€326
no longer reported in 2025 (was €326)
- Profit (loss) carried forward -€1,207
down €1,207 (-11.1%), from -€10,835 to -€12,043
- Tax, wage and social debts +€236
up €236 (+148%), from €159 to €395
- Trade debts -€128
down €128 (-21.1%), from €606 to €478
- Purchases and services -€4,879
no longer reported in 2025 (was €4,879)
- Turnover -€3,584
no longer reported in 2025 (was €3,584)
- Gross operating margin +€1,849
up €1,849, from -€1,296 to €553
- Other operating charges +€1,025
up €1,025 (+590%), from €174 to €1,199
- Depreciation -€73
down €73 (-18.4%), from €399 to €326
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,152 | €1,037 | -€1,115 | -51.8% |
| Fixed assets | 21/28 | €326 | - | -€326 | |
| Tangible fixed assets | 22/27 | €326 | - | -€326 | |
| Plant, machinery and equipment | 23 | €326 | - | -€326 | |
| Current assets | 29/58 | €1,826 | €1,037 | -€789 | -43.2% |
| Amounts receivable within one year | 40/41 | €10 | €10 | = | 0.0% |
| Trade receivables | 40 | €0 | - | = | |
| Other amounts receivable | 41 | €10 | €10 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €1,816 | €1,027 | -€789 | -43.4% |
| Total equity and liabilities | 10/49 | €2,152 | €1,037 | -€1,115 | -51.8% |
| Equity | 10/15 | -€5,835 | -€7,043 | -€1,207 | -20.7% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€10,835 | -€12,043 | -€1,207 | -11.1% |
| Amounts payable | 17/49 | €7,987 | €8,080 | +€92 | +1.2% |
| Amounts payable within one year | 42/48 | €7,987 | €8,080 | +€92 | +1.2% |
| Trade debts | 44 | €606 | €478 | -€128 | -21.1% |
| Suppliers | 440/4 | €606 | €478 | -€128 | -21.1% |
| Advances received on contracts in progress | 46 | €0 | - | = | |
| Taxes, remuneration and social security | 45 | €159 | €395 | +€236 | +148% |
| Taxes | 450/3 | €159 | €395 | +€236 | +148% |
| Other amounts payable | 47/48 | €7,222 | €7,207 | -€16 | -0.2% |
| Turnover | 70 | €3,584 | - | -€3,584 | |
| Goods, raw materials, services and sundry goods | 60/61 | €4,879 | - | -€4,879 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €399 | €326 | -€73 | -18.4% |
| Other operating charges | 640/8 | €174 | €1,199 | +€1,025 | +590% |
| Gross operating margin | 9900 | -€1,296 | €553 | +€1,849 | |
| Operating profit (loss) | 9901 | -€1,868 | -€972 | +€897 | +48.0% |
| Financial income | 75/76B | €0 | €0 | -€0 | -91.3% |
| Recurring financial income | 75 | €0 | €0 | -€0 | -91.3% |
| Financial charges | 65/66B | €164 | €236 | +€72 | +44.1% |
| Recurring financial charges | 65 | €164 | €236 | +€72 | +44.1% |
| Profit (loss) for the period before taxes | 9903 | -€2,031 | -€1,207 | +€824 | +40.6% |
| Profit (loss) for the period | 9904 | -€2,031 | -€1,207 | +€824 | +40.6% |
| Profit (loss) for the period to be appropriated | 9905 | -€2,031 | -€1,207 | +€824 | +40.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.